EDAP TMS Receives FDA Clearance for Enhanced Focal One Robotic HIFU System

EDAP TMS SA received FDA clearance for enhanced ultrasound imaging, streamlined treatment planning, and optimized user interface for its Focal One Robotic HIFU system. This strengthens the company's leadership in robotic focal therapy for prostate cancer. The new features include advanced ultrasound imaging, real-time visualization, and potential AI-driven algorithms for tissue ablation visualization and treatment evaluation.